All subjects except one of group 1 were protected against EAR after salmeterol + BDP ( T3 ) , and MaxdeltaFEV1 % at T3 ( median , 12 % ; range , 4 to 6 % ) was significantly lower than T2 ( median , 22 % ; range , 12 to 43 % ; p < 0.05 by Wilcoxon test ) .
